Mesenchymal stromal cells (MSCs) are a heterogeneous population of cells with secretory, immunomodulatory, and homing properties (Viswanathan et al., 2019). This population encompasses fibroblasts, myofibroblasts, pericytes, and tissue-specific progenitor populations. Traditionally researchers defined in vitro expanded MSCs by (1) plastic adherence, (2) expression of CD73, CD90, and CD105, lack of hematopoietic and endothelial marker expression (CD31, CD34, CD45, HLA-DR), and (3) the capacity to differentiate into adipocyte, chondrocyte and osteoblast lineages in vitro (Dominici et al., 2006). However, despite MSCs from different tissue sources (i.e. bone-marrow, adipose, umbilical cord, placenta) sharing expression of the minimal criteria antigens after in vitro culture, they functionally differ in a tissue-specific manner (Du et al., 2016b; Kozlowska et al., 2019). This has been more recently acknowledged in a refined ISCT position statement that requires the tissue origin of MSCs to be provided along with evidence for their in vitro and in vivo functionality (Viswanathan et al., 2019).

It has become clear that in vitro culture may have significant impact on MSC phenotype, meaning that cultured MSCs may have a different phenotype from their in vivo/freshly isolated counterparts. For example, prior to culture adipose-derived MSCs are CD34+, whilst in vitro culture induces the loss of CD34 expression (Lin et al., 2012). The MSC-associated marker CD271 is also lost with plastic culture (Brooks et al., 2020), and MSC αSMA expression can be heavily impacted by culture media (Boss et al., 2020). Thus, the culture conditions used to expand MSCs can mask their true in vivo phenotype and heterogeneity. Furthermore, in any set of culture conditions the most competitive stromal cells will thrive and take over the culture, whilst other functionally diverse cells may be diluted out or lost. Understanding the true in vivo phenotype, and optimising culture conditions to minimize phenotypic ‘drift’ in vitro may enable researchers to better take advantage of the tissue specific properties of MSCs, and enable more accurate study of their roles in vivo.

Placental MSCs (pMSCs) are routinely isolated from the core of placental villi and propagated in culture (Abumaree et al., 2013; Castrechini et al., 2010; Kusuma et al., 2018). The placenta is a highly vascularised organ that develops rapidly over gestation in order to act as the conduit for nutrient and gas exchange between mother and fetus. pMSCs have been reported to reside in a perivascular niche where they can influence vascular development and function (Castrechini et al., 2010). In line with this, cultured pMSCs have well established angiogenic and haematopoietic paracrine effects in vitro and in vivo (Chen et al., 2009; Du et al., 2016a). pMSCs are typically isolated by gross tissue culture methods (explant outgrowths or enzymatic digestion followed by plastic adherence), rather than by expression of specific cell surface markers (Abumaree et al., 2013; Pelekanos et al., 2016). However, using gross digestion techniques it is impossible to determine the niche in which pMSCs reside. Previous work has assumed that in vitro pMSC expression of CD146, a marker with established perivascular expression in vivo, provides evidence of perivascular origins (Castrechini et al., 2010). However, work with bone marrow MSCs suggest CD146 expression is a tissue culture artefact (Blocki et al., 2013), and chipcytometry has localised in vitro MSC markers CD73, CD105 and CD90 outside of the perivascular niche in term placentae (Consentius et al., 2018). Together this sheds doubt on the perivascular origins of pMSCs, and highlights the need to better characterise their ex vivo phenotype in order to understand their functional role in vivo.

Our understanding of mesenchymal heterogeneity is expanding exponentially, and advances in single-cell technologies have uncovered a wide spectrum of mesenchymal and endothelial phenotypes with specific functions and spatial distributions (Suryawanshi et al., 2018; Takeda et al., 2019; Vijay et al., 2019). Mesenchymal heterogeneity can be used to spatially localise cells, identify cells involved in morphogenesis, angiogenesis or quiescence, and characterise inflammatory, anti-inflammatory, or invasive phenotypes (Cimini and Kishore, 2021; Mezawa et al., 2019; Mezheyeuski et al., 2020; Nazari et al., 2016; Quintanilla et al., 2019). Dramatic advances in flow cytometry over the past few decades have enabled the simultaneous quantification of upwards of 30 antigens, allowing detection of in depth cell heterogeneity. Whilst initiated in the haematopoietic field, the wealth of data produced using multicolour flow cytometry has driven the use of this technique for analysis of other cell types, including the mesenchymal lineages. To date the largest panel used to assess mesenchymal cells (16-colours) was designed for analysis with conventional flow cytometry (Brooks et al., 2020). However, spectral flow cytometry has significant potential to further improve analysis of mesenchymal cells. The ability of spectral flow cytometry to measure a larger portion of the spectral signature of each fluorophore, and thus enable small differences between fluorophores to be discriminated, combined with the ability to remove autofluorescence (a prominent feature of mesenchymal cells) paves the way for assessing cells previously regarded as challenging for multicolour flow cytometry.

Here, we developed what to our knowledge is the largest multicolour spectral flow cytometry panel employed to date, in order to characterise the mesenchymal heterogeneity in first trimester placental tissue, and to ascertain the impact of in vitro MSC culture conditions on the subsequent phenotype of these populations.

Common sources of MSCs used in clinical trials include; uncharacterised adipose, bone-marrow, and placental stroma. Identifying functionally different mesenchymal cells and defining the origins for tissue-specific MSCs could improve these applications. Here, we used a high-dimensional flow cytometry panel to uncover at least four different mesenchymal populations with distinct expression profiles in the villous core of first trimester placentae, indicating the presence of functionally specialised cells. This mesenchymal heterogeneity could translate to different physiological capabilities important for clinical therapies and aid understanding of the role of these cells in vivo.

Characterising the villous core populations allows us to better understand how the placenta functions and develops, and enables targeting of populations for functional analysis. From the four mesenchymal populations classified in this work three populations, perivascular cells (Subset Three), podoplanin⁺CD36⁺ cells (Subset Four), and CD26⁺CD90⁺ myofibroblasts (Subset Five) all closely aligned with populations described in prior single-cell RNA sequencing data from first trimester placentae (Suryawanshi et al., 2018). However, this single-cell RNA sequencing dataset did not report a population that aligned with CD73⁺CD90⁺ cells (Subset Two), instead reporting that only endothelial cells expressed CD73 in the placental core. The ability to assess larger cell numbers by flow cytometry in our work, and the low abundance of CD73⁺CD90⁺ cells after 9 weeks of gestation, means that this population may not have been detected as a distinct population by single cell RNA-seq. Furthermore, RNA expression does not always accurately reflect protein expression (Reimegård et al., 2021). This highlights the importance of protein level characterisation of cells from fresh tissue, and the ability of multicolour flow cytometry to undertake this at single cell resolution complements and builds on single cell gene expression datasets.

The first major aspect of this work to consider is what each subset could represent and what its phenotype reflects. CD73⁺CD90⁺ cells were unique from the other mesenchymal populations and could be identified by their expression of CD73, which was shared only with endothelial cells. The abundance of this population at <10 weeks of gestation hints at their involvement in processes that occur early in gestation such as vasculogenesis or haematopoiesis. CD73⁺CD90⁺ cells co-expressed podoplanin, but were distinct from other mesenchymal subsets in that they did not express CD26. This combined expression pattern alludes to two potential functional roles of these cells in the placenta. First, expression of podoplanin and low expression of CD26 are both associated with a migratory/invasive phenotype (Mezawa et al., 2019; Ward et al., 2019). As the decline in abundance of these cells after 9 weeks of gestation corresponds to the regression of villi and blood vessels from the distal side of the gestational sac (Burton and Jauniaux, 2018), this raises the possibility that CD73⁺CD90⁺ cells could be involved in this regression of the villi, or they arise transiently as the result of an early endothelial to mesenchymal transition in the placenta whereby, endothelial cells involved in vascular regression lose their junctional markers and gain a mesenchymal/migratory phenotype (Pinto et al., 2016). Secondly, expression of podoplanin and a lack of CD26 expression on CD73⁺CD90⁺ cells indicates potential roles in haematopoiesis. Several studies have demonstrated that inhibiting CD26 enhances homing, engraftment and differentiation of hematopoietic stem cells (Christopherson et al., 2004; Kawai et al., 2007), and thus a lack of CD26 expression on CD73⁺CD90⁺ cells could suggest they are involved in blood lineage migration/differentiation as both Hofbauer cells (placental macrophages) and nucleated red blood cells are found in the villous stroma in the first trimester (Van Handel et al., 2007). Furthermore, podoplanin identifies connective stroma in lymphoid organs that produces a network of collagen-rich fibres to enable movement of lymphocytes via interactions with leukocyte CLEC-2 receptors (Link et al., 2011; Nazari et al., 2016; Onak Kandemir et al., 2019; Wang et al., 2011). The stroma of early placental villi is poorly vascularised therefore podoplanin⁺ cells could enable blood lineage cells (including Hofbauer cells) to migrate throughout the villous core (Ingman et al., 2010). Indeed, Hofbauer cells have been co-localised with podoplanin expressing stroma in term placentae (Onak Kandemir et al., 2019). Together this suggests CD73⁺CD90⁺ cells may represent a functionally divergent population, that is abundant in the early first trimester placenta which is specialised to facilitate/promote hematopoietic migration and differentiation, and morphogenesis of the placenta during regression of the distal villi.

The largest subset identified, podoplanin⁺CD36⁺ cells (Subset Four) was hypothesised to constitute the majority of connective villous stroma and play an important role in villous stroma expansion. Similar to CD73⁺CD90⁺ cells, the expression of podoplanin in this population suggests they may play a role in facilitating hematopoietic transport throughout the poorly vascularised first trimester stroma, and may have a migratory phenotype. However, podoplanin⁺CD36⁺ cells had a high expression of CD26 which identifies fibroblasts involved in wound healing/fibrosis and the associated extracellular matrix deposition (Soare et al., 2020; Worthen et al., 2020) suggesting an alternative or additional role in villous expansion and growth. The corresponding podoplanin⁺CD36⁺ population observed in the prior single cell RNA-seq dataset, expressed genes associated with angiogenesis (IL6, ANGPTL-4, TNFAIP6), suggesting they may also provide a paracrine stimulus for placental vascular development which is undergoing vasculogenesis and angiogenesis over first trimester (Chang et al., 2012; Hato et al., 2008; Suryawanshi et al., 2018).

Perivascular cells (Subset Three) were identified by their expression of either CD271 or CD146, both markers that localise in a perivascular niche (Castrechini et al., 2010; Lv et al., 2014). CD26⁺CD90⁺ myofibroblasts (Subset Five) were negative for all other markers in Panel One and therefore, were hypothesised to represent contractile/less proliferative myofibroblasts. Indeed, prior single-cell RNA sequencing work identified that populations aligning with perivascular cells and CD26⁺CD90⁺ myofibroblasts reported here had a respectively low or high expression of markers associated with contractile myofibroblasts and mature perivascular cells (ACTA2 (αSMA) and CNN1 (calponin)) (Kumar et al., 2017; Suryawanshi et al., 2018). The lower expression of contractile markers in perivascular cells in comparison to CD26⁺CD90⁺ myofibroblasts may initially appear unexpected, but as the first trimester placental vasculature is relatively immature it would not necessarily be expected that perivascular cells had high expression of contractile markers at this stage of gestation (Zhang et al., 2002). Interestingly, our in vitro experiments demonstrated that both CD73⁺CD90⁺ cells (Subset Two) and podoplanin⁺CD36⁺ cells (Subset Four) upregulated αSMA and calponin when transferred from EGM-2 to advanced-DMEM/F12, paralleling the upregulation observed in explant-isolated first trimester pMSCs when cultured in this medium (Boss et al., 2020). The in vivo niche that CD73⁺CD90⁺ cells and podoplanin⁺CD36⁺ cells reside in could determine whether differentiated cells contribute to perivascular or myofibroblast contractile cells and more specific markers may be required to tease apart these differences. Indeed, in term placentae contractile perivascular cells express both αSMA and calponin, but extravascular αSMA⁺ cells are also present and thought to allow stem villi to contract and expand in volume (Dellschaft et al., 2020; Farley et al., 2004).

Cultured MSCs are often described as homogeneous. However, there is strong evidence that MSCs upregulate/downregulate markers in response to in vitro culture conditions, and underlying functional and phenotypic heterogeneity could be missed (Blocki et al., 2013; Boss et al., 2020; da Silva Meirelles et al., 2015). In the MSC field, CD73 is thought to be ubiquitously expressed by MSCs (Dominici et al., 2006). However, that podoplanin⁺CD36⁺ cells upregulate CD73 expression after culture demonstrates expression of this marker may also be a culture artefact. The phenotypic convergence of different mesenchymal populations was further demonstrated by the loss of CD36 and CD271 expression, from podoplanin⁺CD36⁺ and CD73⁺CD90⁺ cells respectively, additional markers that made these populations distinct ex vivo. However, expression of CD26 was unaffected by culture, and CD146 was differentiability affected by culture in the two populations. This demonstrates that the nuances of culture adaptation are cell-specific as much as they may be media-specific.

Changes to “MSC” phenotype do not necessarily reflect gain/loss in function. For example bone-marrow MSCs isolated by their expression of CD146 stabilize endothelial tube formation in vitro, whereas, CD146^- MSCs, that subsequently upregulate CD146 in vitro, are unable to stablise tube formation (Blocki et al., 2013). Thus, ex vivo phenotype may be a more accurate indicator of a cells’ functional capacity and highlights the importance of characterizing mesenchymal cells prior to culture. The four placental mesenchymal populations identified here are likely to play different roles in the placenta, and therefore have different functional and therapeutic capacities. pMSCs are often acquired by macerating the villous tissue in order to obtain a single cell suspension that is plated in plastic tissue culture flasks (Papait et al., 2020; Pelekanos et al., 2016). Thus all of the populations identified in this work could be present within such single cell suspensions. However, the population/s with a competitive advantage in culture, either as a result of the culture conditions employed, or as a result of the isolation process itself (enzymes involved, explant-based, plated suspension, enriched for expression of a marker), are likely to outcompete and become the dominant cell in culture. Indeed, our group has demonstrated that under different media conditions fetal pMSCs rather than maternal cells are enriched in culture in EGM-2 (Boss et al., 2020). Characterising the explant isolated pMSCs in more depth in this work demonstrated they express podoplanin, CD26, and CD142, making their origins more likely to be podoplanin⁺CD36⁺ (Subset Four) rather than CD73⁺CD90⁺ cells (Subset Two), perivascular cells (Subset Three) or CD26⁺CD90⁺ myofibroblasts (Subset Five). The heterogeneity identified in this work creates an opportunity to select subsets of these mesenchymal cells more suited to specific uses i.e. with anti-inflammatory/immunomodulatory or angiogenic capacity, and to target media conditions that maintain or transform their in vivo phenotype and desired properties. Furthermore, separately culturing these different subsets will allow us to better to understand their functional contributions to placental development, and whether in vitro culture conditions that promote surface marker convergence also result in functional convergence.

Finally, it is important to consider potential limitations of the use of the cell types identified in therapeutic applications, for example the potential pro-coagulant role of cell surface expression of CD142 (Subset Four) (Moll et al., 2020), or the prior association of CD36 expression (seen on Subset Four) with adipose progenitors, raising the possibility that these cells could be prone to differentiating down this pathway in vivo (Gao et al., 2017; Hanschkow et al., 2022). Conversely, the expression of podoplanin (Subset Two and Four), may indicate an increased migratory capacity, which could potentially enhance migration to sites of therapeutic interest when administered in vivo (Ward et al., 2019). Future work to understand the in vivo and ex vivo functional capacity of each subset identified will help elucidate both their role in placental physiology, and inform potential downstream applications of these cells or their counterparts that may be present in term placentae (a more accessible source of placental cells for therapeutic applications).

In conclusion, this work has demonstrated how simplistic post-culture MSC phenotyping will fail to detect the abundant mesenchymal heterogeneity that exists within the placenta. The phenotypic heterogeneity uncovered in first trimester placental mesenchymal cells indicates their potentially diverse functional roles and highlights the crucial need to thoroughly characterise mesenchymal cells that are used in functional assays or in a therapeutic capacity. The success of this multicolour flow cytometry panel in uncovering mesenchymal cell heterogeneity paves the way for other panels assessing mesenchymal and vascularised tissues. Panels like this could be used to assess cellular dysfunction in pathologies such as cancer, cardiovascular disease and infection, as well as to interrogate different tissues in order to better understand cell function. Identifying the pathological phenotype of mesenchymal/vascular cells in pathologies could lead to therapeutic targets. Indeed, in the context of pregnancy, emerging data has suggested that MSC function is altered in the pregnancy complication fetal growth restriction, with potential impacts on placental vascular function (Boss et al., 2021; Gillmore et al., 2022). Thus, this flow cytometry antibody panel, optimised for placental cells, combined with assessment of different stromal subsets identified in this work, could provide an important tool to better understand normal and abnormal placental development and function across gestation.

FCS data files have been provided for flow cytometry presented in Figures 2-3 following the link: http://flowrepository.org/public_experiment_representations/FR-FCM-Z4TJ Figure 4: http://flowrepository.org/public_experiment_representations/FR-FCM-Z4TL Figure 7: http://flowrepository.org/public_experiment_representations/FR-FCM-Z5FV.

1. 1. Abe K
   2. Shoji M
   3. Chen J
   4. Bierhaus A
   5. Danave I
   6. Micko C
   7. Casper K
   8. Dillehay DL
   9. Nawroth PP
   10. Rickles FR

   (1999) Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor

   PNAS 96:8663–8668.

   https://doi.org/10.1073/pnas.96.15.8663

   • PubMed
   • Google Scholar
2. 1. Abumaree MH
   2. Al Jumah MA
   3. Kalionis B
   4. Jawdat D
   5. Al Khaldi A
   6. Abomaray FM
   7. Fatani AS
   8. Chamley LW
   9. Knawy BA

   (2013) Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages

   Stem Cell Reviews and Reports 9:620–641.

   https://doi.org/10.1007/s12015-013-9455-2

   • Google Scholar
3. 1. Amir ED
   2. Davis KL
   3. Tadmor MD
   4. Simonds EF
   5. Levine JH
   6. Bendall SC
   7. Shenfeld DK
   8. Krishnaswamy S
   9. Nolan GP
   10. Pe’er D

   (2013) viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia

   Nature Biotechnology 31:545–552.

   https://doi.org/10.1038/nbt.2594

   • PubMed
   • Google Scholar
4. 1. Astarita JL
   2. Acton SE
   3. Turley SJ

   (2012) Podoplanin: emerging functions in development, the immune system, and cancer

   Frontiers in Immunology 3:283.

   https://doi.org/10.3389/fimmu.2012.00283

   • PubMed
   • Google Scholar
5. 1. Barilani M
   2. Banfi F
   3. Sironi S
   4. Ragni E
   5. Guillaumin S
   6. Polveraccio F
   7. Rosso L
   8. Moro M
   9. Astori G
   10. Pozzobon M
   11. Lazzari L

   (2018) Low-affinity nerve growth factor receptor (cd271) heterogeneous expression in adult and fetal mesenchymal stromal cells

   Scientific Reports 8:9321.

   https://doi.org/10.1038/s41598-018-27587-8

   • PubMed
   • Google Scholar
6. 1. Blocki A
   2. Wang Y
   3. Koch M
   4. Peh P
   5. Beyer S
   6. Law P
   7. Hui J
   8. Raghunath M

   (2013) Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis

   Stem Cells and Development 22:2347–2355.

   https://doi.org/10.1089/scd.2012.0415

   • PubMed
   • Google Scholar
7. 1. Boss A.L
   2. Brooks AES
   3. Chamley LW
   4. James JL

   (2020) Influence of culture media on the derivation and phenotype of fetal-derived placental mesenchymal stem/stromal cells across gestation

   Placenta 101:66–74.

   https://doi.org/10.1016/j.placenta.2020.09.002

   • PubMed
   • Google Scholar
8. 1. Boss AL
   2. Chamley LW
   3. Brooks AES
   4. James JL

   (2021) Differences in human placental mesenchymal stromal cells may impair vascular function in FGR

   Reproduction 162:319–330.

   https://doi.org/10.1530/REP-21-0226

   • PubMed
   • Google Scholar
9. 1. Brooks AES
   2. Iminitoff M
   3. Williams E
   4. Damani T
   5. Jackson-Patel V
   6. Fan V
   7. James J
   8. Dunbar PR
   9. Feisst V
   10. Sheppard HM

   (2020) Ex vivo human adipose tissue derived mesenchymal stromal cells (asc) are a heterogeneous population that demonstrate rapid culture-induced changes

   Frontiers in Pharmacology 10:1.

   https://doi.org/10.3389/fphar.2019.01695

   • PubMed
   • Google Scholar
10. 1. Burton GJ
    2. Jauniaux E

    (2018) Pathophysiology of placental-derived fetal growth restriction

    American Journal of Obstetrics and Gynecology 218:S745–S761.

    https://doi.org/10.1016/j.ajog.2017.11.577

    • PubMed
    • Google Scholar
11. 1. Castrechini NM
    2. Murthi P
    3. Gude NM
    4. Erwich J
    5. Gronthos S
    6. Zannettino A
    7. Brennecke SP
    8. Kalionis B

    (2010) Mesenchymal stem cells in human placental chorionic villi reside in a vascular Niche

    Placenta 31:203–212.

    https://doi.org/10.1016/j.placenta.2009.12.006

    • PubMed
    • Google Scholar
12. 1. Chang LH
    2. Huang HS
    3. Wu PT
    4. Jou IM
    5. Pan MH
    6. Chang WC
    7. Wang DDH
    8. Wang JM

    (2012) Role of macrophage CCAAT/enhancer binding protein delta in the pathogenesis of rheumatoid arthritis in collagen-induced arthritic mice

    PLOS ONE 7:e45378.

    https://doi.org/10.1371/journal.pone.0045378

    • PubMed
    • Google Scholar
13. 1. Chen CP
    2. Liu SH
    3. Huang JP
    4. Aplin JD
    5. Wu YH
    6. Chen PC
    7. Hu CS
    8. Ko CC
    9. Lee MY
    10. Chen CY

    (2009) Engraftment potential of human placenta-derived mesenchymal stem cells after in utero transplantation in rats

    Human Reproduction 24:154–165.

    https://doi.org/10.1093/humrep/den356

    • PubMed
    • Google Scholar
14. 1. Christopherson KW
    2. Hangoc G
    3. Mantel CR
    4. Broxmeyer HE

    (2004) Modulation of hematopoietic stem cell homing and engraftment by CD26

    Science 305:1000–1003.

    https://doi.org/10.1126/science.1097071

    • PubMed
    • Google Scholar
15. 1. Cimini M
    2. Kishore R

    (2021) Role of podoplanin-positive cells in cardiac fibrosis and angiogenesis after ischemia

    Frontiers in Physiology 12:667278.

    https://doi.org/10.3389/fphys.2021.667278

    • PubMed
    • Google Scholar
16. 1. Consentius C
    2. Mirenska A
    3. Jurisch A
    4. Reinke S
    5. Scharm M
    6. Zenclussen AC
    7. Hennig C
    8. Volk HD

    (2018) In situ detection of CD73+ CD90+ CD105+ lineage: Mesenchymal stromal cells in human placenta and bone marrow specimens by chipcytometry

    Cytometry. Part A 93:889–893.

    https://doi.org/10.1002/cyto.a.23509

    • PubMed
    • Google Scholar
17. 1. Crisan M
    2. Chen CW
    3. Corselli M
    4. Andriolo G
    5. Lazzari L
    6. Péault B

    (2009) Perivascular multipotent progenitor cells in human organs

    Annals of the New York Academy of Sciences 1176:118–123.

    https://doi.org/10.1111/j.1749-6632.2009.04967.x

    • PubMed
    • Google Scholar
18. Report

    1. Cruz-Tapias P
    2. Castiblanco J
    3. Anaya JM

    (2013)

    Major histocompatibility complex: Antigen processing and presentation

    Autoimmunity.

    • Google Scholar
19. 1. da Silva Meirelles L
    2. Malta TM
    3. de Deus Wagatsuma VM
    4. Palma PVB
    5. Araújo AG
    6. Ribeiro Malmegrim KC
    7. Morato de Oliveira F
    8. Panepucci RA
    9. Silva WA Jr
    10. Kashima Haddad S
    11. Covas DT

    (2015) Cultured human adipose tissue pericytes and mesenchymal stromal cells display a very similar gene expression profile

    Stem Cells and Development 24:2822–2840.

    https://doi.org/10.1089/scd.2015.0153

    • PubMed
    • Google Scholar
20. 1. Dellschaft NS
    2. Hutchinson G
    3. Shah S
    4. Jones NW
    5. Bradley C
    6. Leach L
    7. Platt C
    8. Bowtell R
    9. Gowland PA

    (2020) The haemodynamics of the human placenta in utero

    PLOS Biology 18:e3000676.

    https://doi.org/10.1371/journal.pbio.3000676

    • PubMed
    • Google Scholar
21. 1. Demir R
    2. Seval Y
    3. Huppertz B

    (2007) Vasculogenesis and angiogenesis in the early human placenta

    Acta Histochemica 109:257–265.

    https://doi.org/10.1016/j.acthis.2007.02.008

    • PubMed
    • Google Scholar
22. 1. Dominici M
    2. Le Blanc K
    3. Mueller I
    4. Slaper-Cortenbach I
    5. Marini F
    6. Krause D
    7. Deans R
    8. Keating A
    9. Prockop D
    10. Horwitz E

    (2006) Minimal criteria for defining multipotent mesenchymal stromal cells

    The International Society for Cellular Therapy Position Statement. Cytotherapy 8:315–317.

    https://doi.org/10.1080/14653240600855905

    • PubMed
    • Google Scholar
23. 1. Du W
    2. Li X
    3. Chi Y
    4. Ma F
    5. Li Z
    6. Yang S
    7. Song B
    8. Cui J
    9. Ma T
    10. Li J
    11. Tian J
    12. Yang Z
    13. Feng X
    14. Chen F
    15. Lu S
    16. Liang L
    17. Han ZB
    18. Han ZC

    (2016a) VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity

    Stem Cell Research & Therapy 7:49.

    https://doi.org/10.1186/s13287-016-0297-0

    • PubMed
    • Google Scholar
24. 1. Du WJ
    2. Chi Y
    3. Yang ZX
    4. Li ZJ
    5. Cui JJ
    6. Song BQ
    7. Li X
    8. Yang SG
    9. Han ZB
    10. Han ZC

    (2016b) Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta

    Stem Cell Research & Therapy 7:163.

    https://doi.org/10.1186/s13287-016-0418-9

    • PubMed
    • Google Scholar
25. 1. Dye JF
    2. Jablenska R
    3. Donnelly JL
    4. Lawrence L
    5. Leach L
    6. Clark P
    7. Firth JA

    (2001) Phenotype of the endothelium in the human term placenta

    Placenta 22:32–43.

    https://doi.org/10.1053/plac.2000.0579

    • PubMed
    • Google Scholar
26. 1. Farley AE
    2. Graham CH
    3. Smith GN

    (2004) Contractile properties of human placental anchoring villi

    American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 287:R680–R685.

    https://doi.org/10.1152/ajpregu.00222.2004

    • PubMed
    • Google Scholar
27. 1. Ferrer-Font L
    2. Pellefigues C
    3. Mayer JU
    4. Small SJ
    5. Jaimes MC
    6. Price KM

    (2020) Panel design and optimization for high-dimensional immunophenotyping assays using spectral flow cytometry

    Current Protocols in Cytometry 92:e70.

    https://doi.org/10.1002/cpcy.70

    • PubMed
    • Google Scholar
28. 1. Gao H
    2. Volat F
    3. Sandhow L
    4. Galitzky J
    5. Nguyen T
    6. Esteve D
    7. Åström G
    8. Mejhert N
    9. Ledoux S
    10. Thalamas C
    11. Arner P
    12. Guillemot JC
    13. Qian H
    14. Rydén M
    15. Bouloumié A

    (2017) CD36 is a marker of human adipocyte progenitors with pronounced adipogenic and triglyceride accumulation potential

    Stem Cells 35:1799–1814.

    https://doi.org/10.1002/stem.2635

    • PubMed
    • Google Scholar
29. 1. Garcia-Alegria E
    2. Menegatti S
    3. Fadlullah MZH
    4. Menendez P
    5. Lacaud G
    6. Kouskoff V

    (2018) Early human hemogenic endothelium generates primitive and definitive hematopoiesis in vitro

    Stem Cell Reports 11:1061–1074.

    https://doi.org/10.1016/j.stemcr.2018.09.013

    • PubMed
    • Google Scholar
30. 1. Giannotta M
    2. Trani M
    3. Dejana E

    (2013) VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity

    Developmental Cell 26:441–454.

    https://doi.org/10.1016/j.devcel.2013.08.020

    • PubMed
    • Google Scholar
31. 1. Gillmore T
    2. Farrell A
    3. Alahari S
    4. Sallais J
    5. Kurt M
    6. Park C
    7. Ausman J
    8. Litvack M
    9. Post M
    10. Caniggia I

    (2022) Dichotomy in hypoxia-induced mitochondrial fission in placental mesenchymal cells during development and preeclampsia: consequences for trophoblast mitochondrial homeostasis

    Cell Death & Disease 13:191.

    https://doi.org/10.1038/s41419-022-04641-y

    • PubMed
    • Google Scholar
32. 1. Hanschkow M
    2. Boulet N
    3. Kempf E
    4. Bouloumié A
    5. Kiess W
    6. Stein R
    7. Körner A
    8. Landgraf K

    (2022) Expression of the adipocyte progenitor markers msca1 and cd36 is associated with adipose tissue function in children

    The Journal of Clinical Endocrinology and Metabolism 107:e836–e851.

    https://doi.org/10.1210/clinem/dgab630

    • PubMed
    • Google Scholar
33. 1. Hato T
    2. Tabata M
    3. Oike Y

    (2008) The role of angiopoietin-like proteins in angiogenesis and metabolism

    Trends in Cardiovascular Medicine 18:6–14.

    https://doi.org/10.1016/j.tcm.2007.10.003

    • PubMed
    • Google Scholar
34. 1. Heinzelmann K
    2. Lehmann M
    3. Gerckens M
    4. Noskovičová N
    5. Frankenberger M
    6. Lindner M
    7. Hatz R
    8. Behr J
    9. Hilgendorff A
    10. Königshoff M
    11. Eickelberg O

    (2018) Cell-surface phenotyping identifies CD36 and CD97 as novel markers of fibroblast quiescence in lung fibrosis

    American Journal of Physiology. Lung Cellular and Molecular Physiology 315:L682–L696.

    https://doi.org/10.1152/ajplung.00439.2017

    • PubMed
    • Google Scholar
35. 1. Hermiston ML
    2. Xu Z
    3. Weiss A

    (2003) CD45: A critical regulator of signaling thresholds in immune cells

    Annual Review of Immunology 21:107–137.

    https://doi.org/10.1146/annurev.immunol.21.120601.140946

    • PubMed
    • Google Scholar
36. 1. Hubbard AK
    2. Rothlein R

    (2000) Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades

    Free Radical Biology & Medicine 28:1379–1386.

    https://doi.org/10.1016/s0891-5849(00)00223-9

    • PubMed
    • Google Scholar
37. 1. Ingman K
    2. Cookson V
    3. Jones CJP
    4. Aplin JD

    (2010) Characterisation of Hofbauer cells in first and second trimester placenta: incidence, phenotype, survival in vitro and motility

    Placenta 31:535–544.

    https://doi.org/10.1016/j.placenta.2010.03.003

    • PubMed
    • Google Scholar
38. 1. James JL
    2. Hurley DG
    3. Gamage T
    4. Zhang T
    5. Vather R
    6. Pantham P
    7. Murthi P
    8. Chamley LW

    (2015) Isolation and characterisation of a novel trophoblast side-population from first trimester placentae

    Reproduction 150:449–462.

    https://doi.org/10.1530/REP-14-0646

    • PubMed
    • Google Scholar
39. 1. Kawai T
    2. Choi U
    3. Liu PC
    4. Whiting-Theobald NL
    5. Linton GF
    6. Malech HL

    (2007) Diprotin A infusion into nonobese diabetic/severe combined immunodeficiency mice markedly enhances engraftment of human mobilized CD34+ peripheral blood cells

    Stem Cells and Development 16:361–370.

    https://doi.org/10.1089/scd.2007.9997

    • PubMed
    • Google Scholar
40. 1. Kohnen G
    2. Kertschanska S
    3. Demir R
    4. Kaufmann P

    (1996) Placental villous stroma as a model system for myofibroblast differentiation

    Histochemistry and Cell Biology 105:415–429.

    https://doi.org/10.1007/BF01457655

    • PubMed
    • Google Scholar
41. 1. Kotecha N
    2. Krutzik PO
    3. Irish JM

    (2010) Web-based analysis and publication of flow cytometry experiments

    Current Protocols in Cytometry 10:s53.

    https://doi.org/10.1002/0471142956.cy1017s53

    • PubMed
    • Google Scholar
42. 1. Kozlowska U
    2. Krawczenko A
    3. Futoma K
    4. Jurek T
    5. Rorat M
    6. Patrzalek D
    7. Klimczak A

    (2019) Similarities and differences between mesenchymal stem/progenitor cells derived from various human tissues

    World Journal of Stem Cells 11:347–374.

    https://doi.org/10.4252/wjsc.v11.i6.347

    • PubMed
    • Google Scholar
43. 1. Kumar A
    2. D’Souza SS
    3. Moskvin OV
    4. Toh H
    5. Wang B
    6. Zhang J
    7. Swanson S
    8. Guo L-W
    9. Thomson JA
    10. Slukvin II

    (2017) Specification and diversification of pericytes and smooth muscle cells from mesenchymoangioblasts

    Cell Reports 19:1902–1916.

    https://doi.org/10.1016/j.celrep.2017.05.019

    • PubMed
    • Google Scholar
44. 1. Kusuma GD
    2. Abumaree MH
    3. Pertile MD
    4. Kalionis B

    (2018) Isolation and characterization of mesenchymal stem/stromal cells derived from human third trimester placental chorionic villi and decidua basalis

    Methods in Molecular Biology 1710:247–266.

    https://doi.org/10.1007/978-1-4939-7498-6_19

    • PubMed
    • Google Scholar
45. 1. Lax S
    2. Hardie DL
    3. Wilson A
    4. Douglas MR
    5. Anderson G
    6. Huso D
    7. Isacke CM
    8. Buckley CD

    (2010) The pericyte and stromal cell marker CD248 (endosialin) is required for efficient lymph node expansion

    European Journal of Immunology 40:1884–1889.

    https://doi.org/10.1002/eji.200939877

    • PubMed
    • Google Scholar
46. 1. Leroyer AS
    2. Blin MG
    3. Bachelier R
    4. Bardin N
    5. Blot-Chabaud M
    6. Dignat-George F

    (2019) CD146 (cluster of differentiation 146)

    Arteriosclerosis, Thrombosis, and Vascular Biology 39:1026–1033.

    https://doi.org/10.1161/ATVBAHA.119.312653

    • PubMed
    • Google Scholar
47. 1. Li W
    2. Ferkowicz MJ
    3. Johnson SA
    4. Shelley WC
    5. Yoder MC

    (2005) Endothelial cells in the early murine yolk sac give rise to CD41-expressing hematopoietic cells

    Stem Cells and Development 14:44–54.

    https://doi.org/10.1089/scd.2005.14.44

    • PubMed
    • Google Scholar
48. 1. Lin CS
    2. Ning H
    3. Lin G
    4. Lue TF

    (2012) Is CD34 truly a negative marker for mesenchymal stromal cells?

    Cytotherapy 14:1159–1163.

    https://doi.org/10.3109/14653249.2012.729817

    • PubMed
    • Google Scholar
49. 1. Link A
    2. Hardie DL
    3. Favre S
    4. Britschgi MR
    5. Adams DH
    6. Sixt M
    7. Cyster JG
    8. Buckley CD
    9. Luther SA

    (2011) Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans

    The American Journal of Pathology 178:1662–1675.

    https://doi.org/10.1016/j.ajpath.2010.12.039

    • PubMed
    • Google Scholar
50. 1. Lv FJ
    2. Tuan RS
    3. Cheung KMC
    4. Leung VYL
    5. Soleti A
    6. Navone S

    (2014) Concise review: the surface markers and identity of human mesenchymal stem cells

    Stem Cells 32:1408–1419.

    https://doi.org/10.1002/stem.1681

    • PubMed
    • Google Scholar
51. 1. Mao B
    2. Huang S
    3. Lu X
    4. Sun W
    5. Zhou Y
    6. Pan X
    7. Yu J
    8. Lai M
    9. Chen B
    10. Zhou Q
    11. Mao S
    12. Bian G
    13. Zhou J
    14. Nakahata T
    15. Ma F

    (2016) Early development of definitive erythroblasts from human pluripotent stem cells defined by expression of glycophorin A/CD235a, CD34, and CD36

    Stem Cell Reports 7:869–883.

    https://doi.org/10.1016/j.stemcr.2016.09.002

    • PubMed
    • Google Scholar
52. 1. Marelli-Berg FM
    2. Clement M
    3. Mauro C
    4. Caligiuri G

    (2013) An immunologist’s guide to CD31 function in T-cells

    Journal of Cell Science 126:2343–2352.

    https://doi.org/10.1242/jcs.124099

    • PubMed
    • Google Scholar
53. 1. Mezawa Y
    2. Daigo Y
    3. Takano A
    4. Miyagi Y
    5. Yokose T
    6. Yamashita T
    7. Morimoto C
    8. Hino O
    9. Orimo A

    (2019) CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers

    Cancer Medicine 8:3936–3948.

    https://doi.org/10.1002/cam4.2249

    • PubMed
    • Google Scholar
54. 1. Mezheyeuski A
    2. Segersten U
    3. Leiss LW
    4. Malmström P-U
    5. Hatina J
    6. Östman A
    7. Strell C

    (2020) Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome

    Scientific Reports 10:1–12.

    https://doi.org/10.1038/s41598-019-55013-0

    • PubMed
    • Google Scholar
55. 1. Moll G
    2. Drzeniek N
    3. Kamhieh-Milz J
    4. Geissler S
    5. Volk HD
    6. Reinke P

    (2020) MSC therapies for covid-19: importance of patient coagulopathy, thromboprophylaxis, cell product quality and mode of delivery for treatment safety and efficacy

    Frontiers in Immunology 11:1091.

    https://doi.org/10.3389/fimmu.2020.01091

    • PubMed
    • Google Scholar
56. 1. Morrissey JH

    (2004) Tissue factor: A key molecule in hemostatic and nonhemostatic systems

    International Journal of Hematology 79:103–108.

    https://doi.org/10.1532/ijh97.03167

    • PubMed
    • Google Scholar
57. 1. Nazari B
    2. Rice LM
    3. Stifano G
    4. Barron AMS
    5. Wang YM
    6. Korndorf T
    7. Lee J
    8. Bhawan J
    9. Lafyatis R
    10. Browning JL

    (2016) Altered dermal fibroblasts in systemic sclerosis display podoplanin and CD90

    The American Journal of Pathology 186:2650–2664.

    https://doi.org/10.1016/j.ajpath.2016.06.020

    • PubMed
    • Google Scholar
58. 1. Onak Kandemir N
    2. Barut F
    3. Barut A
    4. Birol İE
    5. Dogan Gun B
    6. Ozdamar SO

    (2019) Biological importance of podoplanin expression in chorionic villous stromal cells and its relationship to placental pathologies

    Scientific Reports 9:1–9.

    https://doi.org/10.1038/s41598-019-50652-9

    • PubMed
    • Google Scholar
59. 1. Ou X
    2. O’Leary HA
    3. Broxmeyer HE

    (2013) Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types

    Blood 122:161–169.

    https://doi.org/10.1182/blood-2013-02-487470

    • PubMed
    • Google Scholar
60. 1. Papait A
    2. Vertua E
    3. Magatti M
    4. Ceccariglia S
    5. De Munari S
    6. Silini AR
    7. Sheleg M
    8. Ofir R
    9. Parolini O

    (2020) Mesenchymal stromal cells from fetal and maternal placenta possess key similarities and differences: potential implications for their applications in regenerative medicine

    Cells 9:E127.

    https://doi.org/10.3390/cells9010127

    • PubMed
    • Google Scholar
61. 1. Pelekanos RA
    2. Sardesai VS
    3. Futrega K
    4. Lott WB
    5. Kuhn M
    6. Doran MR

    (2016) Isolation and expansion of mesenchymal stem/stromal cells derived from human placenta tissue

    Journal of Visualized Experiments 1:54204.

    https://doi.org/10.3791/54204

    • PubMed
    • Google Scholar
62. 1. Pinto MT
    2. Covas DT
    3. Kashima S
    4. Rodrigues CO

    (2016) Endothelial mesenchymal transition: comparative analysis of different induction methods

    Biological Procedures Online 18:10.

    https://doi.org/10.1186/s12575-016-0040-3

    • PubMed
    • Google Scholar
63. 1. Quintanilla M
    2. Montero-Montero L
    3. Renart J
    4. Martín-Villar E

    (2019) Podoplanin in inflammation and cancer

    International Journal of Molecular Sciences 20:707.

    https://doi.org/10.3390/ijms20030707

    • PubMed
    • Google Scholar
64. 1. Reimegård J
    2. Tarbier M
    3. Danielsson M
    4. Schuster J
    5. Baskaran S
    6. Panagiotou S
    7. Dahl N
    8. Friedländer MR
    9. Gallant CJ

    (2021) A combined approach for single-cell mRNA and intracellular protein expression analysis

    Communications Biology 4:624.

    https://doi.org/10.1038/s42003-021-02142-w

    • PubMed
    • Google Scholar
65. 1. Roh M
    2. Wainwright DA
    3. Wu JD
    4. Wan Y
    5. Zhang B

    (2020) Targeting CD73 to augment cancer immunotherapy

    Current Opinion in Pharmacology 53:66–76.

    https://doi.org/10.1016/j.coph.2020.07.001

    • PubMed
    • Google Scholar
66. 1. Rönnstrand L

    (2004) Signal transduction via the stem cell factor receptor/c-Kit

    Cellular and Molecular Life Sciences 61:2535–2548.

    https://doi.org/10.1007/s00018-004-4189-6

    • PubMed
    • Google Scholar
67. 1. Ruiz-Argüelles A
    2. Llorente L

    (2007) The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias

    Autoimmunity Reviews 6:155–161.

    https://doi.org/10.1016/j.autrev.2006.09.008

    • PubMed
    • Google Scholar
68. 1. Saldanha-Araujo F
    2. Ferreira FIS
    3. Palma PV
    4. Araujo AG
    5. Queiroz RHC
    6. Covas DT
    7. Zago MA
    8. Panepucci RA

    (2011) Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes

    Stem Cell Research 7:66–74.

    https://doi.org/10.1016/j.scr.2011.04.001

    • PubMed
    • Google Scholar
69. 1. Sidney LE
    2. Branch MJ
    3. Dunphy SE
    4. Dua HS
    5. Hopkinson A

    (2014) Concise review: evidence for CD34 as a common marker for diverse progenitors

    Stem Cells 32:1380–1389.

    https://doi.org/10.1002/stem.1661

    • PubMed
    • Google Scholar
70. 1. Silverstein RL
    2. Febbraio M

    (2009) CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior

    Science Signaling 2:re3.

    https://doi.org/10.1126/scisignal.272re3

    • PubMed
    • Google Scholar
71. 1. Soare A
    2. Györfi HA
    3. Matei AE
    4. Dees C
    5. Rauber S
    6. Wohlfahrt T
    7. Chen C-W
    8. Ludolph I
    9. Horch RE
    10. Bäuerle T
    11. von Hörsten S
    12. Mihai C
    13. Distler O
    14. Ramming A
    15. Schett G
    16. Distler JHW

    (2020) Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis

    Arthritis & Rheumatology 72:137–149.

    https://doi.org/10.1002/art.41058

    • PubMed
    • Google Scholar
72. 1. Soland MA
    2. Bego M
    3. Colletti E
    4. Zanjani ED
    5. St Jeor S
    6. Porada CD
    7. Almeida-Porada G

    (2013) Mesenchymal stem cells engineered to inhibit complement-mediated damage

    PLOS ONE 8:e60461.

    https://doi.org/10.1371/journal.pone.0060461

    • PubMed
    • Google Scholar
73. 1. Suchanski J
    2. Tejchman A
    3. Zacharski M
    4. Piotrowska A
    5. Grzegrzolka J
    6. Chodaczek G
    7. Nowinska K
    8. Rys J
    9. Dziegiel P
    10. Kieda C
    11. Ugorski M

    (2017) Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression

    PLOS ONE 12:e0184970.

    https://doi.org/10.1371/journal.pone.0184970

    • PubMed
    • Google Scholar
74. 1. Suryawanshi H
    2. Morozov P
    3. Straus A
    4. Sahasrabudhe N
    5. Max KEA
    6. Garzia A
    7. Kustagi M
    8. Tuschl T
    9. Williams Z

    (2018) A single-cell survey of the human first-trimester placenta and decidua

    Science Advances 4:eaau4788.

    https://doi.org/10.1126/sciadv.aau4788

    • PubMed
    • Google Scholar
75. 1. Takeda A
    2. Hollmén M
    3. Dermadi D
    4. Pan J
    5. Brulois KF
    6. Kaukonen R
    7. Lönnberg T
    8. Boström P
    9. Koskivuo I
    10. Irjala H
    11. Miyasaka M
    12. Salmi M
    13. Butcher EC
    14. Jalkanen S

    (2019) Single-Cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils

    Immunity 51:561–572.

    https://doi.org/10.1016/j.immuni.2019.06.027

    • PubMed
    • Google Scholar
76. 1. Tomkowicz B
    2. Rybinski K
    3. Sebeck D
    4. Sass P
    5. Nicolaides NC
    6. Grasso L
    7. Zhou Y

    (2010) Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling

    Cancer Biology & Therapy 9:908–915.

    https://doi.org/10.4161/cbt.9.11.11731

    • PubMed
    • Google Scholar
77. 1. Van Handel BJ
    2. Prashad S
    3. Huang A
    4. Hamalainen E
    5. Chen A
    6. Mikkola HKA

    (2007) The first trimester human placenta is a site of primitive red blood cell maturation First Trimester Human Placenta Is a Site of Primitive Red Blood Cell Maturation

    Blood 110:2224.

    https://doi.org/10.1182/blood.V110.11.2224.2224

    • Google Scholar
78. 1. Vijay J
    2. Gauthier MF
    3. Biswell RL
    4. Louiselle DA
    5. Johnston JJ
    6. Cheung WA
    7. Belden B
    8. Pramatarova A
    9. Biertho L
    10. Gibson M
    11. Simon MM
    12. Djambazian H
    13. Staffa A
    14. Bourque G
    15. Laitinen A
    16. Nystedt J
    17. Vohl MC
    18. Fraser JD
    19. Pastinen T
    20. Tchernof A
    21. Grundberg E

    (2019) Single-cell analysis of human adipose tissue identifies depot and disease specific cell types

    Nature Metabolism 2:97–109.

    https://doi.org/10.1038/s42255-019-0152-6

    • PubMed
    • Google Scholar
79. 1. Viswanathan S
    2. Shi Y
    3. Galipeau J
    4. Krampera M
    5. Leblanc K
    6. Martin I
    7. Nolta J
    8. Phinney DG
    9. Sensebe L

    (2019) Mesenchymal stem versus stromal cells: international society for cell & gene therapy (isct) mesenchymal stromal cell committee position statement on nomenclature

    Cytotherapy 21:1019–1024.

    https://doi.org/10.1016/j.jcyt.2019.08.002

    • PubMed
    • Google Scholar
80. 1. Wang Y
    2. Sun J
    3. Gu Y
    4. Zhao S
    5. Groome LJ
    6. Alexander JS

    (2011) D2-40/podoplanin expression in the human placenta

    Placenta 32:27–32.

    https://doi.org/10.1016/j.placenta.2010.10.014

    • PubMed
    • Google Scholar
81. 1. Ward LSC
    2. Sheriff L
    3. Marshall JL
    4. Manning JE
    5. Brill A
    6. Nash GB
    7. McGettrick HM

    (2019) Podoplanin regulates the migration of mesenchymal stromal cells and their interaction with platelets

    Journal of Cell Science 132:jcs222067.

    https://doi.org/10.1242/jcs.222067

    • PubMed
    • Google Scholar
82. 1. Worthen CA
    2. Cui Y
    3. Orringer JS
    4. Johnson TM
    5. Voorhees JJ
    6. Fisher GJ

    (2020) CD26 identifies a subpopulation of fibroblasts that produce the majority of collagen during wound healing in human skin

    The Journal of Investigative Dermatology 140:2515–2524.

    https://doi.org/10.1016/j.jid.2020.04.010

    • PubMed
    • Google Scholar
83. 1. Yoder MC

    (2009) Defining human endothelial progenitor cells

    Journal of Thrombosis and Haemostasis 7 Suppl 1:49–52.

    https://doi.org/10.1111/j.1538-7836.2009.03407.x

    • PubMed
    • Google Scholar
84. 1. Zhang EG
    2. Burton GJ
    3. Smith SK
    4. Charnock-Jones DS

    (2002) Placental vessel adaptation during gestation and to high altitude: changes in diameter and perivascular cell coverage

    Placenta 23:751–762.

    https://doi.org/10.1016/s0143-4004(02)90856-8

    • PubMed
    • Google Scholar
85. 1. Zhao H
    2. Bo C
    3. Kang Y
    4. Li H

    (2017) What else can CD39 tell us?

    Frontiers in Immunology 8:727.

    https://doi.org/10.3389/fimmu.2017.00727

    • PubMed
    • Google Scholar

Author details

1. Anna Leabourn Boss

   1. Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
   2. School of Biological Sciences, University of Auckland, Auckland, New Zealand

   Contribution

   Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft

   For correspondence

   a.boss@auckland.ac.nz

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-1943-4162

2. Tanvi Damani

   School of Biological Sciences, University of Auckland, Auckland, New Zealand

   Contribution

   Investigation

   Competing interests

   No competing interests declared

3. Tayla J Wickman

   Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

   Contribution

   Data curation, Formal analysis

   Competing interests

   No competing interests declared

4. Larry W Chamley

   Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

   Contribution

   Writing – review and editing

   Competing interests

   No competing interests declared

5. Joanna L James

   Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

   Contribution

   Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Project administration, Writing – review and editing

   Contributed equally with

   Anna ES Brooks

   Competing interests

   No competing interests declared

6. Anna ES Brooks

   1. School of Biological Sciences, University of Auckland, Auckland, New Zealand
   2. Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand

   Contribution

   Conceptualization, Resources, Software, Supervision, Funding acquisition, Methodology, Writing – review and editing

   Contributed equally with

   Joanna L James

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-3551-6982

• 1,263

  views

• 228

  downloads

• 7

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.